Fort Myers, Fla., August 29, 2022 – Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified hematologist/oncologist Shivtaj Mann, DO to the statewide practice. He is providing care to patients at the FCS Fort Myers Cancer Center, 8260 Gladiolus Drive, Fort Myers, FL 33908.
Board-certified in Internal Medicine, Dr. Mann received his Doctor of Osteopathic Medicine degree from NOVA Southeastern University in Fort Lauderdale, FL. He completed residency training in Internal Medicine at Lehigh Valley Health Network in Allentown, PA and a fellowship in Hematology Oncology at the University of Arizona in Tucson. His research projects have been published in scientific journals, including the American Journal of Kidney Diseases.
FCS Chief Executive Officer Nathan H. Walcker said, “A native of Coral Springs, Florida, Dr. Mann has a special interest in providing world-class cancer care to his patients and building long-term relationships throughout the local community.”
“Dr. Mann’s expertise and special interest in benign and malignant hematology as well as the diagnosis and treatment of lung and genitourinary cancers and melanoma will enhance the scope of care FCS provides to its patients in and around Lee County,” said FCS President & Managing Physician Michael Diaz, MD said. “We are delighted to welcome him to our practice.”
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Michelle Robey, VP of Marketing
Jennifer Bradley, Director of Corporate Communications